Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundUbrogepant is a successful drug used for the therapy of migraine. Purpose: The objective of this work was to formulate a novel nanoparticle-based therapy using ubrogepant for optimum therapeutic efficacy by quick and sustained action.MethodsThe …